日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Intermittent fasting enhances cisplatin-metformin efficacy in therapy-resistant ovarian cancer PDXs.

间歇性禁食可增强顺铂-二甲双胍对治疗耐药性卵巢癌PDX模型的疗效。

Capellini Elena, Perotti Ludovica, Guffanti Federica, De Simone Giulia, Morabito Aurelia, Ronchi Anna Maria, Sala Laura, Scanziani Eugenio, Corna Daniela, Cerullo Domenico, Matteo Cristina, Fruscio Robert, Brunelli Laura, Damia Giovanna, Ricci Francesca

Cross-Cultural Adaptation and Validation of KidSIM Attitude Towards Teamwork in Training Undergoing Designed Educational Simulation (ATTITUDES) in Undergraduate Healthcare Professionals

KidSIM 团队合作态度量表在本科医疗保健专业人员培训中的跨文化适应性和验证

Garzon, Simone; Campetti, Elisa; Panzeri, Maria; Fumagalli, Simona; Nespoli, Antonella; Locatelli, Anna; Fruscio, Robert; Serafini, Marzia; Antolini, Laura; Valletta, Sabrina; Adami, Anna; Bosco, Mariachiara; Franchi, Massimo Piergiuseppe; Uccella, Stefano

Imaging in gynecological disease (29): clinical and ultrasound features of primary ovarian immature teratoma

妇科疾病影像学(29):原发性卵巢未成熟畸胎瘤的临床和超声特征

Landolfo, C; Froyman, W; Testa, A C; Fischerova, D; Franchi, D; Yazbek, J; Saso, S; Fruscio, R; Chiappa, V; Czekierdowski, A; Van Gorp, T; Moro, F; Savelli, L; Zannoni, G F; Bourne, T; Timmerman, D; Valentin, L

International multicenter validation of AI-driven ultrasound detection of ovarian cancer

国际多中心验证人工智能驱动的超声检测卵巢癌

Christiansen, Filip; Konuk, Emir; Ganeshan, Adithya Raju; Welch, Robert; Palés Huix, Joana; Czekierdowski, Artur; Leone, Francesco Paolo Giuseppe; Haak, Lucia Anna; Fruscio, Robert; Gaurilcikas, Adrius; Franchi, Dorella; Fischerova, Daniela; Mor, Elisa; Savelli, Luca; Pascual, Maria Àngela; Kudla, Marek Jerzy; Guerriero, Stefano; Buonomo, Francesca; Liuba, Karina; Montik, Nina; Alcázar, Juan Luis; Domali, Ekaterini; Pangilinan, Nelinda Catherine P; Carella, Chiara; Munaretto, Maria; Saskova, Petra; Verri, Debora; Visenzi, Chiara; Herman, Pawel; Smith, Kevin; Epstein, Elisabeth

Clinical Behavior of Breast Cancer in Young BRCA Carriers and Prediagnostic Awareness of Germline BRCA Status

年轻BRCA基因携带者乳腺癌的临床表现及诊断前对生殖系BRCA状态的认知

Lambertini, Matteo; Blondeaux, Eva; Tomasello, Loredana M; Agostinetto, Elisa; Hamy, Anne-Sophie; Kim, Hee Jeong; Franzoi, Maria Alice; Bernstein-Molho, Rinat; Hilbers, Florentine; Pogoda, Katarzyna; Wildiers, Hans; Bajpai, Jyoti; Ignatiadis, Michail; Moore, Halle C F; Partridge, Ann H; Phillips, Kelly-Anne; Toss, Angela; Rousset-Jablonski, Christine; Criscitiello, Carmen; Renaud, Tiphaine; Ferrari, Alberta; Paluch-Shimon, Shani; Fruscio, Robert; Cui, Wanda; Wong, Stephanie M; Vernieri, Claudio; Ruddy, Kathryn J; Dieci, Maria Vittoria; Matikas, Alexios; Rozenblit, Mariya; Villarreal-Garza, Cynthia; De Marchis, Laura; Puglisi, Fabio; Rodriguez-Wallberg, Kenny A; Duhoux, Francois P; Livraghi, Luca; Bruzzone, Marco; Boni, Luca; Balmaña, Judith

Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study

根据 BRCA1/2 突变类型和部位评估新诊断卵巢癌患者接受 PARP 抑制剂维持治疗的获益:一项多中心真实世界研究

Marchetti, C; Fagotti, A; Fruscio, R; Cassani, C; Incorvaia, L; Perri, M T; Sassu, C M; Camnasio, C A; Giudice, E; Minucci, A; Seca, M; Arbustini, E; Vertechy, L; De Bonis, M; Boccia, S M; Giannarelli, D; Salutari, V; Distefano, M; Ferrandina, M G; Nero, C; Musacchio, L; Russo, A; Scambia, G; Lorusso, D

Response to letter re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study: Not all BRCA mutations are equal: functional context and mutation type as co-determinants of PARP inhibitor response

关于“根据BRCA1/2突变类型和部位评估PARP抑制剂维持治疗对新诊断卵巢癌患者的益处:一项多中心真实世界研究”的来信回复:并非所有BRCA突变都相同:功能背景和突变类型是PARP抑制剂疗效的共同决定因素

Marchetti, C; Fagotti, A; Fruscio, R; Cassani, C; Incorvaia, L; Perri, M T; Sassu, C M; Camnasio, C A; Giudice, E; Minucci, A; Seca, M; Arbustini, E; Vertechy, L; De Bonis, M; Boccia, S M; Giannarelli, D; Salutari, V; Distefano, M; Ferrandina, M G; Nero, C; Musacchio, L; Russo, A; Scambia, G; Lorusso, D

Response to letter re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study

回复关于“根据BRCA1/2突变类型和部位评估PARP抑制剂维持治疗对新诊断卵巢癌患者的益处:一项多中心真实世界研究”的来信

Marchetti, C; Fagotti, A; Fruscio, R; Cassani, C; Incorvaia, L; Perri, M T; Sassu, C M; Camnasio, C A; Giudice, E; Minucci, A; Seca, M; Arbustini, E; Vertechy, L; De Bonis, M; Boccia, S M; Giannarelli, D; Salutari, V; Distefano, M; Ferrandina, M G; Nero, C; Musacchio, L; Russo, A; Scambia, G; Lorusso, D

Parity, breastfeeding, and the risk of early-onset breast cancer in women with a BRCA1 pathogenic variant

生育次数、母乳喂养与携带 BRCA1 致病变异的女性罹患早发性乳腺癌的风险

Kotsopoulos, Joanne; Maxwell, Christopher A; Lubinski, Jan; Huzarski, Tomasz; Kim, Raymond H; Tung, Nadine; Eisen, Andrea; Foulkes, William; Aeilts, Amber; Neuhausen, Susan L; Bordeleau, Louise; Khokha, Rama; Pal, Tuya; Karlan, Beth; Fruscio, Robert; Couch, Fergus; Sun, Ping; Gronwald, Jacek; Narod, Steven A

The incidence of pancreatic cancer in women with a BRCA1 or BRCA2 mutation

携带 BRCA1 或 BRCA2 突变的女性罹患胰腺癌的概率

Katona, Bryson W; Lubinski, Jan; Pal, Tuya; Huzarski, Tomasz; Foulkes, William D; Moller, Pal; Eisen, Andrea; Randall Armel, Susan; Neuhausen, Susan L; Raj, Rebecca; Aeilts, Amber; Singer, Christian F; Bordeleau, Louise; Karlan, Beth; Olopade, Olufunmilayo; Tung, Nadine; Zakalik, Dana; Kotsopoulos, Joanne; Fruscio, Robert; Eng, Charis; Sun, Ping; Narod, Steven A